REMODULIN for Pulmonary hypertension: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 11 adverse event reports in the FDA FAERS database where REMODULIN was used for Pulmonary hypertension.
Most Reported Side Effects for REMODULIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 95 | 13.7% | 93 | 8 |
| Dyspnoea | 79 | 11.4% | 4 | 71 |
| Device related infection | 64 | 9.2% | 1 | 63 |
| Drug dose omission | 42 | 6.0% | 1 | 37 |
| Nausea | 32 | 4.6% | 0 | 25 |
| Headache | 30 | 4.3% | 0 | 18 |
| Diarrhoea | 28 | 4.0% | 1 | 19 |
| Pulmonary arterial hypertension | 28 | 4.0% | 10 | 20 |
| Vomiting | 28 | 4.0% | 1 | 24 |
| Fluid retention | 27 | 3.9% | 1 | 23 |
| Pneumonia | 27 | 3.9% | 1 | 25 |
| Hypotension | 24 | 3.5% | 3 | 20 |
| Fall | 23 | 3.3% | 2 | 16 |
| Infusion site pain | 21 | 3.0% | 0 | 10 |
| Dizziness | 20 | 2.9% | 0 | 15 |
Other Indications for REMODULIN
Pulmonary arterial hypertension (372)
Cor pulmonale chronic (220)
Product used for unknown indication (56)
Other Drugs Used for Pulmonary hypertension
AMBRISENTAN (18,885)
TREPROSTINIL (10,034)
MACITENTAN (5,228)
RIOCIGUAT (3,837)
SILDENAFIL (3,761)
SELEXIPAG (2,500)
EPOPROSTENOL (2,486)
TADALAFIL (2,430)
BOSENTAN (2,337)
ILOPROST (1,123)